Candesartan's Effects on Alzheimer's Disease And Related Biomarkers

NCT02646982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Placebo
DRUG: Candesartan

Sponsor

Emory University

Collaborators

[object Object]